About Us

RRI Group, Inc. is a Full Service Global Regulatory and Management Company that collaborates with pharmaceutical, device, and biotech companies in the development of novel branded and generic therapeutics and devices.

We specializing in NDA, especially the 505(b)(2), and ANDA programs.  RRI Group, Inc. facilitates obtaining FDA approvals by delivering high quality regulatory and clinical strategies, solutions and services, with the demonstrated ability to save our clients time and money.

RRI Group, Inc. services include the full spectrum of program management, regulatory, clinical, data management and analysis, and compliance and audit services. RRI Group, Inc. leverages its access to well renowned researchers, regulatory personnel, and facilities, in North America, Europe, Oceania, and Asia, to achieve unparalleled scientific, clinical, and business results while reducing the time of development and approval that significantly lowers the costs to our clients.

RRI Group, Inc. is headquartered in Lake Wylie, SC, near Charlotte, NC, and has regional offices and associates across the globe.

"Specialists in 505(b)(2) NDA/ANDA/Regulatory & Development Services"

We invite you to contact us about your drug development needs, as well as our cGMP, cGCP and cGLP inspections and auditing services. We can build a foundation for your product development needs.

CONTACT US

RRI Group, Inc.
248 Latitude Lane, Suite 104
Lake Wylie, SC 29710
Phone: 803-831-7657
Fax:     803-831-1494
email

"Specialists in 505(b)(2) NDA/ANDA/Regulatory & Development Services"











Trends in 505(b)(2)Approvals
By Loren Gelber, Chief Scientific Officer at RRI Group, Inc



SPA Symposium, Baltimore MD: 

"Highway to Higher Profits"
Call RRI to learn more!        
803.831.7657

» more